[1] |
BUCKMASTER A E, SCOTT S D, SANDERSON M J, et al. Gene sequence and mapping data from Marek's disease virus and herpesvirus of turkeys:implications for herpesvirus classification[J]. J Gen Virol, 1988, 69(8):2033-2042.
|
[2] |
DUNN J R, BLACK PYRKOSZ A, STEEP A, et al. Identification of Marek's disease virus genes associated with virulence of US strains[J]. J Gen Virol, 2019, 100(7):1132-1139.
|
[3] |
OSTERRIEDER N, KAMIL J P, SCHUMACHER D, et al. Marek's disease virus:from miasma to model[J]. Nat Rev Microbiol, 2006, 4(4):283-294.
|
[4] |
NAIR V. Evolution of Marek's disease-a paradigm for incessant race between the pathogen and the host[J]. Vet J, 2005, 170(2):175-183.
|
[5] |
CALNEK B W, SCHAT K A, ROSS L J N, et al. Further characterization of Marek's disease virus-infected lymphocytes. Ⅱ. In vitro infection[J]. Int J Cancer, 1984, 33(3):399-406.
|
[6] |
ABDUL-CAREEM M F, HUNTER B D, LEE L F, et al. Host responses in the bursa of Fabricius of chickens infected with virulent Marek's disease virus[J]. Virology, 2008, 379(2):256-265.
|
[7] |
SHEK W R, CALNEK B W, SCHAT K A, et al. Characterization of Marek's disease virus-infected lymphocytes:discrimination between cytolytically and latently infected cells[J]. J Natl Cancer Inst, 1983, 70(3):485-491.
|
[8] |
ABDUL-CAREEM M F, HUNTER B D, SARSON A J, et al. Host responses are induced in feathers of chickens infected with Marek's disease virus[J]. Virology, 2008, 370(2):323-332.
|
[9] |
ABDUL-CAREEM M F, READ L R, PARVIZI P, et al. Marek's disease virus-induced expression of cytokine genes in feathers of genetically defined chickens[J]. Dev Comp Immunol, 2009, 33(4):618-623.
|
[10] |
COUTEAUDIER M, DENESVRE C. Marek's disease virus and skin interactions[J]. Vet Res, 2014, 45(1):36.
|
[11] |
CALNEK B W, ADLDINGER H K, KAHN D E. Feather follicle epithelium:a source of enveloped and infectious cell-free herpesvirus from Marek's disease[J]. Avian Dis, 1970, 14(2):219-233.
|
[12] |
SCHAT K A, CHEN C L, CALNEK B W, et al. Transformation of T-lymphocyte subsets by Marek's disease herpesvirus[J]. J Virol, 1991, 65(3):1408-1413.
|
[13] |
LIU S, CHEN S, ZENG J. TGF-β signaling:a complex role in tumorigenesis (Review)[J]. Mol Med Rep, 2018, 17(1):699-704.
|
[14] |
APONTE-LÓPEZ A, FUENTES-PANANÁ E M, CORTES-MUÑOZ D, et al. Mast cell, the neglected member of the tumor microenvironment:role in breast cancer[J]. J Immunol Res, 2018, 2018:2584243.
|
[15] |
MITTAL S, BROWN N J, HOLEN I. The breast tumor microenvironment:role in cancer development, progression and response to therapy[J]. Expert Rev Mol Diagn, 2018, 18(3):227-243.
|
[16] |
YU T J, DI G H. Role of tumor microenvironment in triple-negative breast cancer and its prognostic significance[J]. Chin J Cancer Res, 2017, 29(3):237-252.
|
[17] |
NARKHEDE A A, SHERWOOD J A, ANTONE A, et al. Role of surface chemistry in mediating the uptake of ultrasmall iron oxide nanoparticles by cancer cells[J]. ACS Appl Mater Interfaces, 2019, 11(19):17157-17166.
|
[18] |
CLARK D A, COKER R. Molecules in focus transforming growth factor-beta (TGF-β)[J]. Int J Biochem Cell Biol, 1998, 30(3):293-298.
|
[19] |
IKUSHIMA H, MIYAZONO K. TGFβ signalling:a complex web in cancer progression[J]. Nat Rev Cancer, 2010, 10(6):415-424.
|
[20] |
DERYNCK R, AKHURST R J, BALMAIN A. TGF-β signaling in tumor suppression and cancer progression[J]. Nat Genet, 2001, 29(2):117-129.
|
[21] |
陈玉红, 狄翠霞, 张倩婧, 等. TGF-β/Smads信号传导通路在肿瘤中的作用[J]. 生理科学进展, 2018, 49(3):187-192.CHEN Y H, DI C X, ZHANG Q Q, et al. The role of TGF-β/Smads signal transduction pathways in tumors[J]. Progress in Physiological Sciences, 2018, 49(3):187-192. (in Chinese)
|
[22] |
YANG L, PANG Y L, MOSES H L. TGF-β and immune cells:an important regulatory axis in the tumor microenvironment and progression[J]. Trends Immunol, 2010, 31(6):220-227.
|
[23] |
UNGEFROREN H, GIESELER F, KAUFMANN R, et al. Signaling crosstalk of TGF-β/ALK5 and PAR2/PAR1:a complex regulatory network controlling fibrosis and cancer[J]. Int J Mol Sci, 2018, 19(6):1568.
|
[24] |
PAPOUTSOGLOU P, LOUIS C, COULOUARN C. Transforming growth factor-beta (TGFβ) signaling pathway in cholangiocarcinoma[J]. Cells, 2019, 8(9):960.
|
[25] |
GORDON K J, BLOBE G C. Role of transforming growth factor-β superfamily signaling pathways in human disease[J]. Biochim Biophys Acta, 2008, 1782(4):197-228.
|
[26] |
MASSAGUÉ J. How cells read TGF-β signals[J]. Nat Rev Mol Cell Biol, 2000, 1(3):169-178.
|
[27] |
ROBERTS A B, WAKEFIELD L M. The two faces of transforming growth factor β in carcinogenesis[J]. Proc Natl Acad Sci U S A, 2003, 100(15):8621-8623.
|
[28] |
AULA H, SKYTTÄ T, TUOHINEN S, et al. Decreases in TGF-β1 and PDGF levels are associated with echocardiographic changes during adjuvant radiotherapy for breast cancer[J]. Radiat Oncol, 2018, 13(1):201.
|
[29] |
ZU X Y, ZHONG J, TAN J J, et al. TGF-β1 induces HMGA1 expression in human breast cancer cells:implications of the involvement of HMGA1 in TGF-β signaling[J]. Int J Mol Med, 2015, 35(3):693-701.
|
[30] |
余祖华, 丁轲, 郁川, 等. gga-miR-155对MDCC-MSB1细胞生物学行为的影响[J]. 畜牧兽医学报, 2018, 49(11):2496-2504.YU Z H, DING K, YU C, et al. Effect of gga-miR-155 on the biological behavior of MDCC-MSB1 cells[J]. Acta Veterinaria et Zootechnica Sinica, 2018, 49(11):2496-2504. (in Chinese)
|
[31] |
SHARIAT S F, KIM J H, ANDREWS B, et al. Preoperative plasma levels of transforming growth factor β1 strongly predict clinical outcome in patients with bladder carcinoma[J]. Cancer, 2001, 92(12):2985-2992.
|
[32] |
CHEN J L, WALTON K L, HAGG A, et al. Specific targeting of TGF-β family ligands demonstrates distinct roles in the regulation of muscle mass in health and disease[J]. Proc Natl Acad Sci U S A, 2017, 114(26):E5266-E5275.
|
[33] |
TUCKER R F, SHIPLEY G D, MOSES H L, et al. Growth inhibitor from BSC-1 cells closely related to platelet type beta transforming growth factor[J]. Science, 1984, 226(4675):705-707.
|
[34] |
PIETENPOL J A, HOLT J T, STEIN R W, et al. Transforming growth factor beta 1 suppression of c-myc gene transcription:role in inhibition of keratinocyte proliferation[J]. Proc Natl Acad Sci U S A, 1990, 87(10):3758-3762.
|
[35] |
PILLAIRE M J, CASAGRANDE F, MALECAZE F, et al. Regulation by transforming growth factor-β1 of G1 cyclin-dependent kinases in human retinal epithelial cells[J]. Exp Eye Res, 1999, 68(2):193-199.
|
[36] |
MURAOKA R S, DUMONT N, RITTER C A, et al. Blockade of TGF-β inhibits mammary tumor cell viability, migration, and metastases[J]. J Clin Invest, 2002, 109(12):1551-1559.
|
[37] |
MANSOURI-ATTIA N, TRIPURANI S K, GOKUL N, et al. TGFβ signaling promotes juvenile granulosa cell tumorigenesis by suppressing apoptosis[J]. Mol Endocrinol, 2014, 28(11):1887-1898.
|
[38] |
SUN W H, XU Y Y, ZHAO C, et al. Targeting TGF-β1 suppresses survival of and invasion by anaplastic thyroid carcinoma cells[J]. Am J Transl Res, 2017, 9(3):1418-1425.
|
[39] |
SEOANE J, GOMIS R R. TGF-β family signaling in tumor suppression and cancer progression[J]. Cold Spring Harb Perspect Biol, 2017, 9(12):a022277.
|
[40] |
CHI J Q, TENG M, YU Z H, et al. Marek's disease virus-encoded analog of microRNA-155 activates the oncogene c-Myc by targeting LTBP1 and suppressing the TGF-β signaling pathway[J]. Virology, 2015, 476:72-84.
|